Does SOTORASIB Cause Disease progression? 314 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 314 reports of Disease progression have been filed in association with SOTORASIB (LUMAKRAS). This represents 10.7% of all adverse event reports for SOTORASIB.
314
Reports of Disease progression with SOTORASIB
10.7%
of all SOTORASIB reports
83
Deaths
9
Hospitalizations
How Dangerous Is Disease progression From SOTORASIB?
Of the 314 reports, 83 (26.4%) resulted in death, 9 (2.9%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for SOTORASIB.
What Other Side Effects Does SOTORASIB Cause?
Non-small cell lung cancer (483)
Death (319)
Diarrhoea (284)
Off label use (193)
Nausea (98)
Non-small cell lung cancer metastatic (93)
Hepatotoxicity (91)
Fatigue (87)
Hepatic function abnormal (80)
Aspartate aminotransferase increased (71)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which SOTORASIB Alternatives Have Lower Disease progression Risk?
SOTORASIB vs SOTROVIMAB
SOTORASIB vs SOVALDI
SOTORASIB vs SOYBEAN OIL
SOTORASIB vs SPARSENTAN
SOTORASIB vs SPARTALIZUMAB